MYCOF OTC
Noveris Health Sciences Inc.
1W: +0.0%
1M: +0.0%
3M: -63.5%
YTD: +234.9%
1Y: +12066.7%
3Y: +350.6%
5Y: +96.8%
$0.73
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$42.7M
52W Range0.029-2.04
Volume1,000
Avg Volume2,774
Beta-5.44
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJason Birmingham
Employees3
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2021-01-08
Websitenoveris.health
789 West Pender Street
Vancouver, BC V6E 3C9
CA
Vancouver, BC V6E 3C9
CA
720-277-9879
About Noveris Health Sciences Inc.
Noveris Health Sciences Inc. operates as a biotechnology firm dedicated to the investigation, pharmaceutical development, and clinical evaluation of psilocybin-based products. Co-founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013, the company maintains its headquarters in Vancouver, Canada.
Recent Insider Trades
No insider trades found